Pancreatitic Mutation Panel Test
Test Name: Pancreatitic Mutation Panel Test
Components: EDTA Vacutainer (2ml)
Price: 5700.0 AED
Sample Condition: Peripheral blood
Report Delivery: 4-6 weeks
Method: NGS (Next-Generation Sequencing)
Test Type: Genetics
Doctor: General Physician
Test Department: Pre Test Information
Pancreatitic mutation panel can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details:
A pancreatic mutation panel is a genetic test that analyzes specific genes associated with pancreatic cancer. The panel typically includes genes such as KRAS, TP53, CDKN2A, SMAD4, and BRCA2, among others. These genes are known to be frequently mutated in pancreatic cancer and can provide valuable information for diagnosis, prognosis, and treatment planning. The test is usually performed on a blood or tissue sample and can help identify individuals who may have an increased risk of developing pancreatic cancer or who may benefit from targeted therapies.
Test Name | Pancreatitic mutation panel Test |
---|---|
Components | EDTA Vacutainer (2ml) |
Price | 5700.0 AED |
Sample Condition | Peripheral blood |
Report Delivery | 4-6 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Pancreatitic mutation panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
A pancreatic mutation panel is a genetic test that analyzes specific genes associated with pancreatic cancer. The panel typically includes genes such as KRAS, TP53, CDKN2A, SMAD4, and BRCA2, among others. These genes are known to be frequently mutated in pancreatic cancer and can provide valuable information for diagnosis, prognosis, and treatment planning. The test is usually performed on a blood or tissue sample and can help identify individuals who may have an increased risk of developing pancreatic cancer or who may benefit from targeted therapies. |